Stephen Clulow

Stephen Clulow PhD is currently serving as the President of NineSigma Europe and North America, where Stephen helps companies and organizations understand the external environment, find new collaborators, and create successful deals. Stephen also founded Action for Innovation, focusing on healthcare innovation through open innovation and crowd sourcing. Additionally, Stephen has experience as a Funding Assessor for Innovate UK and a New Business Opportunities Assessor for Small Business Research Initiative. Prior to their current roles, Stephen held leadership positions at companies such as AstraZeneca and Cambridge Antibody Technology. Stephen holds a PhD in Genetics from the University of East Anglia and an MSc in Innovation, Creativity and Leadership from City, University of London.